Inhibition of soluble epoxide hydrolase by extracts derived from inflammation-treating Chinese medicinal herbs

Phytotherapy Research

Volumn 22, Issue 9, 2008, Pages 1264-1268

  Shi, Da Hua ^a   Xu, Chen ^a   Guo, Bin Xin ^a   Wang, Xiao Ting ^a   Chen, Yun Xi ^a   Tan, Ren Xiang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chinese medicinal herbs; Inflammation; Inhibition; Soluble epoxide hydrolase

Indexed keywords

ACORUS GRAMINEUS EXTRACT; APIALES EXTRACT; AQUIFOLIACEAE EXTRACT; ARACEAE EXTRACT; ARISTOLOCHIA MOLLISSIMA EXTRACT; ASTERACEAE EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; BERBERIDACEAE EXTRACT; BUPLEURUM CHINENSE EXTRACT; CINNAMOMUM CASSIA EXTRACT; CUPRESSACEAE EXTRACT; EPIMEDIUM BREVICORNUM EXTRACT; EPOXIDE HYDROLASE; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; HIPPOPHAE RHAMNOIDES EXTRACT; ILEX PUBESCENS EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; MAGNOLIA OFFICINALIS EXTRACT; PHELLODENDRON AMURENSE EXTRACT; PLANT EXTRACT; RHUBARB EXTRACT; SAPOSHNIKOVIA DIVARICATA EXTRACT; SAUSSUREA LAPPA EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SIEGESBECKIA ORIENTALIS EXTRACT; SOPHORA FLAVESCENS EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHIUM SIBIRICUM EXTRACT;

ACORUS GRAMINEUS; ANEMONE ALTAICA; ANGIOSPERM; APIALES; AQUIFOLIACEAE; ARACEAE; ARISTOLOCHIA MOLLISSIMA; ARTICLE; ASTERACEAE; ASTRAGALUS MEMBRANACEUS; BERBERIDACEAE; BLETILLA STRIATA; BUPLEURUM CHINENSE; CASSIA ANGUSTIFOLIA; CASSIA OCCIDENTALIS; CHINESE MEDICINE; CINNAMOMUM CASSIA; CLOVE; CUPRESSACEAE; DRUG SCREENING; ELAEAGNACEAE; ENZYME INHIBITION; EPIMEDIUM BREVICORNUM; FENNEL; FLUORESCENCE; FRITILLARIA THUNBERGII; GENTIANA MANSHURICA; GENTIANACEAE; GLYCYRRHIZA URALENSIS; HERB; HIPPOPHAE RHAMNOIDES; IC 50; ILEX PUBESCENS; INFLAMMATION; LEGUME; LIGUSTICUM CHUANXIONG; LILIUM BROWNII; LINDERA STRYCHNIFOLIA; LYSIMACHIA CHRISTINAE; MAGNOLIA DENUDATA; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MELIA TOOSENDAN; MELIACEAE; MENISPERMACEAE; MENTHA HAPLOCALYX; MYRTACEAE; ORCHIDACEAE; PHELLODENDRON AMURENSE; PHYTOCHEMISTRY; PIPER LONGUM; PIPERACEAE; PLANT ROOT; PLATYCLADUS ORIENTALIS; POLYGALA TENUIFOLIA; POLYGALACEAE; POLYGONUM MULTIFLORUM; PRIMULACEAE; RANUNCULACEAE; RHUBARB; RUTACEAE; SAPOSHNIKOVIA DIVARICATA; SAUSSUREA LAPPA; SCHISANDRA CHINENSIS; SCROPHULARIA NINGPOCNSIS; SCROPHULARIACEAE; SCUTELLARIA BARBATA; SIEGESBECKIA ORIENTALIS; SINOMENIUM ACUTUM; SOPHORA FLAVESCENS; SOPHORA TONKINENSIS; SWERTIA MUSSOTII; SWERTIA PSEUDOCHINENSIS; TINOSPORA SAGITTATA; TRIGONELLA FOENUM; XANTHIUM SIBIRICUM;

DRUGS, CHINESE HERBAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; EPOXIDE HYDROLASES; HUMANS; INFLAMMATION; PLANT EXTRACTS; RECOMBINANT PROTEINS;

FABACEAE; SOPHORA FLAVESCENS;

EID: 52649160781     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2326     Document Type: Article

References (11)

1. Bao YW, Li C, Shen HW, Nan FJ. 2004. Determination of saikosaponin derivatives in Radix bupleuri and in pharmaceuticals of the Chinese multiherb remedy xiaochaihu-tang using liquid chromatographic tandem mass spectrometry. Anal Chem 76: 4208-4216.
2. Beetham JK, Tian T, Hammock BD. 1993. cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch Biochem Biophys 305: 197-201.
3. Campbell WB. 2000. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol Sci 21: 125-127.
4. Fujisawa Y, Sakamoto M, Matsushita M, Fujita T, Nishioka K. 2000. Glycyrrhizin inhibits the lytic pathway of complement-possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis. Microbiol Immunol 44: 799-804.
5. Jones PD, Wolf NM, Morisseau C, Whetstone P, Hock B, Hammock BD. 2005. Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Anal Biochem 343: 66-75.
6. Kim IH, Morisseau C, Watanabe T, Hammock BD. 2004. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. J Med Chem 47: 2110-2122.
7. Morisseau C, Hammock BD. 2005. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol 45: 311-333.
8. Smith KR, Pinkerton KE, Watanabe T, Pedersen TL, Ma SJ, Hammock BD. 2005. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA 102: 2186-2191.
9. Su XD, Wang XK, Li Y et al. 2001. Determination of alkaloids in Sophora flavescens Ait. and Sophora viciifolia Hance by capillary zone electrophoresis. J Microcolumn Sep 13: 221-226.
10. Vane JR, Botting RM. 1998. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47(Suppl. 2): S78-S87.
11. Wixtrom RN, Hammock BD. 1985. Membrane-bound and soluble-fraction epoxide hydrolases: methodological aspects. In Biochemical Pharmacology and Toxicology. Vol. 1. Methodological Aspects of Drug Metabolizing Enzymes, Zakim D, Vessey DA (eds). Wiley: New York, 1-93.